Loading…
CIK 0001822947 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ally-bridge-group-ny-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $3.8M | 3.0% | 33,712 SH | New |
| ALUMIS INC | COM | $3.7M | 3.0% | 166,959 SH | New |
| AN2 THERAPEUTICS INC | COM | $1.8M | 1.5% | 526,315 SH | New |
| CAPRICOR THERAPEUTICS INC | COM NEW | $3.5M | 2.8% | 113,899 SH | New |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $5.8M | 4.7% | 1,045,000 SH | New |
| COMPASS THERAPEUTICS INC | COM | $5.3M | 4.3% | 1,000,000 SH | New |
| CYTOMX THERAPEUTICS INC. | COM | $4.2M | 3.4% | 900,000 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $5.1M | 4.1%Prev: 2.0% | 161,000 SH | Increased+58,350 SH |
| EUPRAXIA PHARMACEUTICALS INC | COM | $4.8M | 3.9% | 660,375 SH | New |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $2.2M | 1.8% | 1,325,000 SH | New |
| INVENTIVA SA | ADS | $4.1M | 3.3% | 745,300 SH | New |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $1.4M | 1.1% | 250,000 SH | New |
| MAZE THERAPEUTICS INC | COM | $3.0M | 2.4% | 100,000 SH | New |
| MINERVA NEUROSCIENCES INC | COM NEW | $10.0M | 8.1% | 1,655,500 SH | New |
| OVID THERAPEUTICS INC | COM | $6.3M | 5.1% | 2,818,459 SH | New |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $3.9M | 3.1% | 926,557 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $10.6M | 8.5%Prev: 3.3% | 32,810 SH | Increased-62,772 SH |
| PROMIS NEUROSCIENCES INC | COM SHS | $5.3M | 4.2% | 414,219 SH | New |
| RELMADA THERAPEUTICS INC | COM | $1.5M | 1.2% | 210,525 SH | New |
| REPLIMUNE GROUP INC | COM | $1.9M | 1.5% | 246,900 SH | New |
| SOLENO THERAPEUTICS INC | COM | $13.4M | 10.8%Prev: 7.8% | 400,000 SH | Increased+279,551 SH |
| SOLID BIOSCIENCES INC | COM NEW | $5.5M | 4.5% | 766,974 SH | New |
| TARSUS PHARMACEUTICALS INC | COM | $5.7M | 4.6%Prev: 5.9% | 80,859 SH | Decreased-47,073 SH |
| UNIQURE NV | SHS | $4.9M | 4.0% | 300,000 SH | New |
| UROGEN PHARMA LTD | COM | $3.6M | 2.9% | 202,124 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $2.8M | 2.3%Prev: 1.3% | 817,939 SH | Increased |
| 13F-HR |
| 0001193125-26-352338 |
| $113.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008419 | $120.2M | View |
| May 18, 2026 | Q1 2026 | 13F-HR | 0001193125-26-227559 | $123.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005586 | $110.9M | View |